---
title: Collaboration with Cancer Parents｜Medilead,Inc
description: An introduction to initiatives in collaboration with “Cancer Parents,” a community that supports cancer patients balancing parenting and employment. This page highlights the shared commitment to preventing social isolation and promoting social participation, as well as details of activities such as research projects, events, and Medilead’s partnership efforts.
---

[![Medilead, Inc.](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/logo.png)](https://www.medi-l.com/en?hsLang=en)

- [Service](https://www.medi-l.com/en/introduction?hsLang=en) 
    - [Marketing Research](https://www.medi-l.com/en/market-intelligence?hsLang=en)
    - [Strategic Partner](https://www.medi-l.com/en/strategicpartner?hsLang=en)
    - [Data Science](https://www.medi-l.com/en/medical-affairs?hsLang=en)
    - [Healthcare database](https://www.medi-l.com/en/medilead-marketplace?hsLang=en)
- [News](https://www.medi-l.com/en/news-list?hsLang=en)
- [About us](https://www.medi-l.com/en/about-us?hsLang=en) 
    - [Company](https://www.medi-l.com/en/company?hsLang=en)
    - [Philosophy](https://www.medi-l.com/en/philosophy?hsLang=en)
    - [Top Message](https://www.medi-l.com/en/top-message?hsLang=en)
    - [with “Cancer Parents”](https://www.medi-l.com/en/cancer-parent?hsLang=en)
- Japanese  English
- [Contact us](https://www.medi-l.com/en/contact-us?hsLang=en)

About us

Partnering with “Cancer Parents” in the cancer patient community

[Top](https://www.medi-l.com/en?hsLang=en) ＞ [About us](https://www.medi-l.com/en/about-us?hsLang=en) ＞ With Cancer parents

Partnering with “Cancer Parents” in the cancer patient community

 

The history and background of our partnership with Cancer Parents

Organization for cancer patients who are working parents of children

The late Yohei Nishiguchi founded Cancer Parents in 2016 after being diagnosed with stage IV cancer at the age of 35. Mr. Nishiguchi created a place for cancer patients who are also working parents to connect with one another. As a medical and healthcare company, Medilead has supported Cancer Parents since its founding.

To eliminate the alienation from society that affects cancer patients

Cancer Parents aims to not only connect cancer patients in similar circumstances, but also empower them to engage in economic and social activities as independent members of society.  
Cancer Parents’ vision stems from the sense of "alienation from society" that Mr. Nishiguchi himself felt. Cancer is a disease that varies from person to person, and there are many patients who are still able to work as usual. However, being a cancer patient often changes the way people view you, and there are many patients who are unable to engage normally in social activities as a result.

 

 

"Partnering" to bring a positive influence to social and economic activities

“Connecting cancer patients to support one another in participating in ‘normal’ economic and social activities…” In this, Cancer Parents and Medilead share a similar philosophy: To pursue our happiness and the future of healthcare.  
Above all, as a company conducting marketing research in the medical and healthcare fields, we believe that working with Cancer Patients as "partners" rather than "supporters" will help create a more positive influence on each other’s social and economic activities.   
Through this connection, our company has continued to work with Cancer Patients on various occasions up to the present.

Future Prospects

Speak for and express the thoughts and feelings of cancer patients

While we have a tendency to provide cancer patients with special treatment, their true desire is to be treated normally and to lead a normal social life.  
As a company that conducts research, we are able to project and communicate the true feelings of cancer patients—which are often difficult to convey to the general public—to the world. We hope to continue creating opportunities for cancer patients to communicate their thoughts and being the impetus that empowers them to lead normal lives.

 

The page of Cancer Parents

[![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/logo-wide.png)](https://www.cancer-parents.org/)

お知らせおよび自主調査

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2024.02.28

[【キャンサーペアレンツ・メディリード共同自主調査】がん患者さんがおこなっているアピアランス（見た目）への対処と、求めるサポートとは](https://www.medi-l.com/blog/medileadlabo-article/oncology/n0040?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2024.02.14

[【キャンサーペアレンツ・メディリード共同自主調査】がん患者さんのアピアランス変化の実態](https://www.medi-l.com/blog/medileadlabo-article/oncology/n0039?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2023.03.07

[キャンサーペアレンツがあり続けるためにできること　|　【キャンサーペアレンツ×メディリード座談会】Vol.3](https://www.medi-l.com/blog/medileadlabo-article/n0012?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2023.02.21

[みんなががんについて「知る」ことの大切さ　|　【キャンサーペアレンツ×メディリード座談会】Vol.2](https://www.medi-l.com/blog/medileadlabo-article/n0011?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2023.02.07

[キャンサーペアレンツに参加してからの変化とは　|　【キャンサーペアレンツ×メディリード座談会】Vol.1](https://www.medi-l.com/blog/medileadlabo-article/n0010?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2020.10.12

[当社とキャンサーペアレンツの共同調査をNHKで取り上げていただきました](https://www.medi-l.com/blog/medileadlabo-article/medilead_news_20201012?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2019.03.15

[キャンサーペアレンツと共同で調査サービス「キャンサーベイ」を提供～がん患者さんの声を広く社会へ発信～](https://www.medi-l.com/blog/medileadlabo-article/medilead_news_20190315?hsLang=en)

![...](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/_i_icon_02118_icon_021180_256.png)

2016.09.28

[キャンサーぺアレンツ×株式会社メディリード対談](https://www.medi-l.com/blog/medileadlabo-article/n0001?hsLang=en)

For corporate inquiries about the business of Medilead Inc., please press this button and contact us.

[Contact us](https://www.medi-l.com/en/contact-us?hsLang=en)

![Medilead, Inc.](https://www.medi-l.com/hubfs/raw_assets/public/medilead-hubspot-theme/wp-content/themes/twentytwentyone-child/asset/images/logo.png)

Tokyo Opera City Tower (24F) 3-20-2, Nishishinjuku Shinjuku-ku, Tokyo, 163-1424 Japan

TEL : +81-3-6859-2295 FAX : +81-3-6745-1168

[Services](https://www.medi-l.com/en/introduction?hsLang=en)

 Marketing Research

[introduction](https://www.medi-l.com/en/market-intelligence?hsLang=en)

Strategic Partner

[introduction](https://www.medi-l.com/en/strategicpartner?hsLang=en)

Data Science

[introduction](https://www.medi-l.com/en/medical-affairs?hsLang=en)

Healthcare Database

[introduction](https://www.medi-l.com/en/medilead-marketplace?hsLang=en)

[About us](https://www.medi-l.com/en/about-us?hsLang=en)

[Company](https://www.medi-l.com/en/company?hsLang=en)

[Philosophy](https://www.medi-l.com/en/philosophy?hsLang=en)

[Top message](https://www.medi-l.com/en/top-message?hsLang=en)

[With Cancer parents](https://www.medi-l.com/en/cancer-parent?hsLang=en)

[News](https://www.medi-l.com/en/news-list?hsLang=en)

[Contact us](https://www.medi-l.com/en/contact-us?hsLang=en)

[Privacy Policy](https://www.medi-l.com/en/privacy?hsLang=en)

<https://www.medi-l.com/en/?hsLang=en>Top Page

<https://twitter.com/medilead_com> <https://www.instagram.com/medilead_com/> <https://www.facebook.com/profile.php?id=61550633949288> <https://www.tiktok.com/@medilead?lang=ja-JP>

2025 © Medilead Inc. All Rights Reserved.

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.medi-l.com/#organization",
  "@type" : "Organization",
  "alternateName" : [ "Medilead", "株式会社メディリード", "メディリード" ],
  "legalName" : "株式会社メディリード",
  "logo" : "https://www.medi-l.com/hubfs/243993822/logo/logo_170x170.png",
  "name" : "Medilead, Inc.",
  "url" : "https://www.medi-l.com/en/"
}
```